SUBSCRIBE
SUBSCRIBE
News   Business

Pacific Biosciences Appoints Michael J. Glynn as Chief Commercial Officer

October 4, 2011 | 
1 min read
MENLO PARK, Calif.--(BUSINESS WIRE)--Pacific Biosciences of California, Inc. (NASDAQ: PACB), provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael J. Glynn as Chief Commercial Officer.
People
PacBio
MORE ON THIS TOPIC
Earnings
Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue Up 46% in Q4
February 4, 2026
 · 
1 min read
 · 
Annalee Armstrong
shopping cart loaded with pills with dollar signs around it on a light blue background
Earnings
Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-Launches
February 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Pfizer’s Metsera Data, 2025 Earnings, the FDA and REGENXBIO, Psychedelics and IPOs
February 4, 2026
 · 
1 min read
 · 
Heather McKenzie
A close-up of a zebra standing in the Okavango Delta, showcasing its distinctive black and white stripes. The background is a blur of natural vegetation.
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
February 4, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker